rhodioloside has been researched along with Brain Swelling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Fu, Q; Jiang, W; Luo, F; Ma, C; Ma, Z; Wei, T; Yan, T; Zhang, K; Zhou, R; Zhu, L | 1 |
| Chen, CC; Chen, SF; Hung, TH; Lee, CY; Liao, NC; Tsai, HJ; Wang, PY; Wu, CH | 1 |
2 other study(ies) available for rhodioloside and Brain Swelling
| Article | Year |
|---|---|
Suppressing Receptor-Interacting Protein 140: a New Sight for Salidroside to Treat Cerebral Ischemia.
Topics: Animals; bcl-2-Associated X Protein; Brain; Brain Edema; Brain Ischemia; Cell Line, Tumor; Cell Survival; Cytokines; Glucosides; Humans; Male; NF-kappa B; Nuclear Receptor Co-Repressor 1; Phenols; Rats, Sprague-Dawley; Signal Transduction | 2016 |
Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3K/Akt signaling after experimental traumatic brain injury.
Topics: Antioxidants; Apoptosis; Brain Edema; Brain Injuries; Cells, Cultured; Cerebral Cortex; Chromones; Dose-Response Relationship, Drug; Glucosides; Hippocampus; Injections, Intraperitoneal; Mitochondria; Morpholines; Motor Activity; Neurons; Neuroprotective Agents; Organ Specificity; Phenols; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rotarod Performance Test; Signal Transduction; Stress, Physiological | 2012 |